Latest Exploration News

Trek Metals has marked a breakthrough year with a high-grade manganese discovery at its Christmas Creek Project in Western Australia, supported by strong assay results and expanded exploration tenure. The company bolstered its balance sheet with $19.5 million raised to fund drilling and further exploration.

Catalina Resources is fast-tracking exploration across its newly acquired Mid-West portfolio in WA, targeting gold and base metals with drilling planned within six weeks. The company’s strategic positioning near the Kirkalocka processing plant and a recent capital raise underpin its near-term development ambitions.

Carnarvon Energy has locked in the Transocean Equinox rig for a pivotal 2027 drilling campaign targeting major prospects in the Bedout Sub-basin, with costs comfortably covered by its strong cash reserves.

Adavale Resources has boosted its Parkes Project gold resource by 44% to 166,000 ounces through a 100% scrip acquisition of the Calarie mining licence and three exploration licences, consolidating its belt-scale position in NSW’s Lachlan Fold Belt.

FMR Resources has received final assays from drillhole 26LHDD073 at its Southern Porphyry target, confirming extensive copper-gold-molybdenum mineralisation and supporting the interpretation of a large porphyry system. Ongoing integration of geological and geophysical data aims to refine targets ahead of Phase II drilling.

Orange Minerals NL has agreed to sell its 51% interest in the Calarie Project tenements to Adavale Resources, receiving shares and options in return. This move supports Orange Minerals' focus on its core gold projects in Ghana and Western Australia.

Canadian Phosphate (ASX: CP8) is raising up to AUD 4.85 million via a renounceable rights issue at a 22% discount, aiming to accelerate development of its newly acquired Diamond Mountain Project in Utah and advance exploration in Canada.

Venus Metals has sold its 1% Youanmi gold royalty to Franco-Nevada for $46 million, triggering plans for $35 million in special dividends and an in-specie distribution of Rox shares to shareholders.

Evion Group has increased the size of its second tranche placement, lifting total capital raised to A$7.24 million through the issue of over 241 million shares at 3 cents each. The second tranche awaits shareholder approval at a July meeting, including director participation and free attaching options.

Bass Oil Limited offers up to 24 million free attaching options to recent placement participants, alongside nearly 8 million options to its lead manager PAC Partners, with no new funds raised from the options issue.

Sarama Resources has secured A$1.42 million through the first tranche of its A$1.5 million equity placement, with the second tranche involving director participation pending shareholder approval.

Amplia Therapeutics reported encouraging mature data from its ACCENT pancreatic cancer trial showing improved survival and response rates with narmafotinib. The company raised $27.5 million to fund development and manufacturing scale-up, while discontinuing a parallel trial due to chemotherapy toxicity.